Year: 2025
Type: article
Study design: Case Report
Abstract: A 41-year-old woman with Anaplastic Lymphoma Kinase (ALK) gene positive adenocarcinoma of the lung presented with dyspnea in the 4th month of Crizotinib therapy with a prominent finding of bilateral mild pleural effusion.A comprehensive radiological and laboratory investigation discounted infection, rheumatological diseases and malignancies, while the symptoms and pleural effusion regressed after pausing Crizotinib medication.We present this unusual case of lymphocytic pleural effusion associated with Crizotinib, which is a novel tyrosine kinase inhibitor.
Source: Respiratory Case Reports
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4411831462